Navigation Links
Ceramide can target and kill cancer cells,,

Research by the scientists from Penn State College of Medicine brought to light that injecting ceramide// into the blood stream it is possible to target and kill breast cancer cells.

Ceramide is a natural substance that accumulates in the cancer cells and thus may be used to get better results out of breast cancer treatments. Researchers had used their techniques on mice for successful results.

However injecting ceramide in the usual way into the blood stream can have severe toxic results. Scientists, to overcome this, have used nanotechnology to create capsules of ceramides called liposomes. Such a way makes it easy for the capsules to move in the blood stream and release the ceramides in the tumor cells. This happens as ceramides are, by nature still unknown to scientists, attracted to tumor cells.

The liposome-encased ceramides reaches the tumor cells via the bloodstream. Then it enters the tumor cells through the vasculature, and disrupts the mitochondria of the cells. In mice these bundles of ceramide targets and destroys only breast cancer cells, leaving the surrounding cells healthy and functional.

The results of the study came up in the new issue of the journal Clinical Cancer Research.

Reference: Penn State University, Press Release, May 2005
'"/>




Page: 1

Related medicine news :

1. Ceramide Directs Stem Cells in Embryo
2. Feeding channel created by malaria parasite - a new target for malaria treatments
3. Enzyme may be target for obesity drugs
4. Scios Inc. targets drug giants in arthritis war
5. Pharmaceutical companies are targeting patients
6. New target for antidiabetic agents identified
7. Multi targeted approach required for suicide prevention in adolescents
8. GPs discontented with 48-hour target
9. Maori diabetes project way off target
10. Microcapsules target cancer cells
11. Indian American Scientist at Work on Multi-targeted Drug
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/5/2016)... , ... February 05, 2016 , ... ... setting the stage for new clinical and scientific initiatives have all marked the ... she was appointed President and CEO of the nation’s oldest cancer center, Candace ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... ... College President George H. Van Allen have signed a joint enrollment and degree ... a seamless pathway toward associate and baccalaureate degrees at FHU|Dickson. , The ...
(Date:2/5/2016)... ... 05, 2016 , ... The American public tends to feel uncomfortable about drinking ... regular municipal or well water. The recent experience with lead contaminated water in Flint, ... long way toward increasing public acceptance of recycled waste water as drinking water. ...
(Date:2/5/2016)... ... 05, 2016 , ... At its annual meeting held last week, the American ... National Board of Directors. Mr. McDermott succeeds former APDA Chairman, Fred Greene. , "We ... Chambers , APDA President and CEO. “Pat has tirelessly served APDA since 2001 when ...
(Date:2/5/2016)... ... February 05, 2016 , ... In sleep, when the defenses of the day ... feature of patients with eating disorders is significant self-criticism, and consequently these patients experience ... are regarded as maladaptive means for coping with this unease, but also leads to ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... CENTENNIAL, Colo. , Feb. 5, 2016  As ... about health. The multitude of recommended screenings and tests ... healthy aging a priority. However, for the majority of ... of proactive health planning. For the 37.5 million American ... time like the present to make hearing health a ...
(Date:2/5/2016)... 2016 Aethlon Medical, Inc. (Nasdaq: AEMD ), ... will be presenting at Source Capital Group,s 2016 Disruptive Growth ... at 2:15 p.m. ET on Wednesday, February 10, 2016.  ... taking place at 3:15 p.m. ET. http://www.aethlonmedical.com .  ... after the conclusion of the live event. The panel discussion ...
(Date:2/5/2016)... 2016  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... underwritten secondary offering of 11,027,558 shares of its common ... of Blackstone and Goldman Sachs.  The shares are being ... $96.45 per share. The selling stockholders will receive all ... nor any of its directors, officers or other stockholders ...
Breaking Medicine Technology: